S troke is a major public health problem that not only is the third leading cause of death in Japan but also induces functional disabilities and cognitive decline. A preventive approach to ischemic brain damage and neuronal loss leads to an improved quality of life in individuals. Possible gender differences have been reported in stroke. For example, most epidemiological studies have shown that men have a higher stroke incidence than women. 1 Such a gender difference in stroke incidence might be caused by the beneficial effects of estrogen on the brain in premenopausal women. In basic experiments using animal models, estrogen appeared to protect against ischemic brain damage by protection of the endothelial function and neurons. 2,3 However, the stroke incidence was increased in postmenopausal women whose serum estradiol level was the same as or less than the level in men. Conversely, the Women's Health Initiative clinical trials on hormone therapy raised an alert that estrogen treatment after menopause increases the risk of stroke and venous thromboembolic disease. 4 Therefore, the effect of estrogen is not a simple answer for explaining the gender difference in stroke incidence. Silent brain infarction (SBI) is identified by brain imaging in healthy patients without clinical symptoms and has been investigated since the 1990s. 5 The incidence of SBI in the general population is relatively high; overall, its prevalence is around 11%. 6 The presence of SBI may allow us to clinically predict overt stroke in the future. 6,7 In Japanese patients, the risk of clinical stroke was significantly higher in subjects with SBI (around a threefold increase) than in those without SBI; 8 therefore, the presence of SBI could tell us of the need for an interventional approach to prevent the onset of severe cerebral ischemia. The risk factors for SBI, such as metabolic syndrome, 9 hypertension 10 and smoking, 6 have been reported previously. Interestingly, among older Japanese subjects, white-coat hypertensives do not show an increase in the prevalence of SBI compared with normotensives. 11 However, the predicted risk factors differ from the observed results depending on the study population. Moreover, there are few population-based studies of the gender difference in SBI incidence among Japanese people.In this issue of Hypertension Research, Takashima et al. 12 focus on the gender difference in SBI incidence among Japanese people with a population-based, cross-sectional analysis. The study comprised 266 men and 414 women with a mean age of 64.5 years. Their findings are similar to previous studies; for example, the prevalence of SBI found in this study was 11.3%. However, daily habits such as smoking and alcohol intake are quite different between men and women. Interestingly, the authors reported that a higher prevalence of such lifestyle risk factors rather than gender explains the male predominance in the incidence of SBI. Although men have a higher incidence of SBI, the gender differences disappeared after adjusting for the r...